Related Experiment Video
Updated: Aug 8, 2026
08:02
Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model
Published on: March 6, 2012
The basis for current treatment recommendations for malignant gliomas
1Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Ma.
Journal of Neuro-Oncology
|January 1, 1994
Summary
Advances in treating primary brain tumors, particularly malignant gliomas, are slow due to limited high-quality clinical trials. Future progress requires better understanding of tumor biology and improved trial design for effective therapies.
Area of Science:
- Neuro-oncology
- Cancer Research
- Clinical Trial Design
Background:
- Primary brain tumors are a significant cause of cancer mortality.
- Treatment advances lag behind systemic cancers, largely due to trial limitations.
Purpose of the Study:
- To review the challenges and progress in treating malignant gliomas.
- To highlight the need for improved clinical trial methodologies.
Main Methods:
- Analysis of data from prospective, multi-institutional randomized trials.
- Review of existing literature on radiation and chemotherapy for brain tumors.
Main Results:
- Radiation therapy has a defined role in malignant glioma treatment.
- The role of chemotherapy is established for a subset of patients, but remains unclear for most.
Conclusions:
- Progress in malignant glioma treatment is hampered by small patient numbers and heterogeneous trial data.
- Enhanced understanding of tumor biology and optimized clinical trial design are crucial for future therapeutic advancements.
